155 related articles for article (PubMed ID: 30596969)
1. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.
Yoon S; Kim M; Min HK; Lee YU; Kwon DH; Lee M; Lee S; Kook T; Joung H; Nam KI; Ahn Y; Kim YK; Kim J; Park WJ; McMullen JR; Eom GH; Kook H
Cardiovasc Res; 2019 Nov; 115(13):1850-1860. PubMed ID: 30596969
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
[TBL] [Abstract][Full Text] [Related]
3. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart.
Yoon S; Kook T; Min HK; Kwon DH; Cho YK; Kim M; Shin S; Joung H; Jeong SH; Lee S; Kang G; Park Y; Kim YS; Ahn Y; McMullen JR; Gergs U; Neumann J; Kim KK; Kim J; Nam KI; Kim YK; Kook H; Eom GH
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 30050113
[TBL] [Abstract][Full Text] [Related]
4. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
5. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
6. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
7. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy.
Eleftheriadou O; Boguslavskyi A; Longman MR; Cowan J; Francois A; Heads RJ; Wadzinski BE; Ryan A; Shattock MJ; Snabaitis AK
Basic Res Cardiol; 2017 Jul; 112(4):37. PubMed ID: 28526910
[TBL] [Abstract][Full Text] [Related]
9. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
12. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
[TBL] [Abstract][Full Text] [Related]
13. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
[TBL] [Abstract][Full Text] [Related]
14. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
[TBL] [Abstract][Full Text] [Related]
15. Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats.
Patel BM
Cardiovasc Toxicol; 2018 Feb; 18(1):1-8. PubMed ID: 28389765
[TBL] [Abstract][Full Text] [Related]
16. Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy.
Sorriento D; Santulli G; Franco A; Cipolletta E; Napolitano L; Gambardella J; Gomez-Monterrey I; Campiglia P; Trimarco B; Iaccarino G; Ciccarelli M
J Cardiovasc Transl Res; 2015 Nov; 8(8):493-502. PubMed ID: 26224342
[TBL] [Abstract][Full Text] [Related]
17. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
18. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
